1Ziswiler R,Steinmann-Niggli K,Kappele A,et al.Mycophenolic acid:a new approach to the therapy of experimental mesangial proliferative glomerulonephritis.J Am Soc Nephrol,1998,9:2055-2066.
2Tan EM,Cohen AS,Fries JF,et al.The 1982 revised criteria for the classification of systemic lupus erythematosus.Arthritis Rheum,1982,25:1271-1277.
3Fulton B,Markham A.Mycophenolate mofetil:a review of its pharmacodynamic and pharmcokinetic properties and clinical efficacy in renal transplantation.Drug,1996,51:278-298.
4Abduo NI,Sweiman B,Casella SR.Effects of azathioprine therapy on bone marrow-dependent and thymus-dependent cells in man.Clin Exp Immunol,1973,13:55-64.
5US Renal Transplant Mycophenolate Mofetil Study Group.Mycophenolate mofetil in cadaveric renal transplantation.Am J Kidney Dis,1999,34:296-303.
6Dooley MA,Cosio FG,Nachman PH,et al.Mycophenolate mofetil therapy in lupus nephritis:clinical observations.J Am Soc Nephrol,1999,10:833-839.
